default author photo

Asuka Yoshida

Pfizer, Inc.

SCHOLARLY PAPERS

1

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Global, Regional, and National Estimates of Adult Respiratory and Cardiorespiratory Hospitalisations Attributable to Respiratory Syncytial Virus From 2015 to 2022: Application of the Global Burden of Disease Framework

Number of pages: 27 Posted: 10 Apr 2026
Katrin Burkart, Quinn Rafferty, Caihua Liang, Catherine W. Gillespie, Andrei Oros, Jam Suba, Ana Grajales, Caroline Lade, Kristian Lie, Andreas Palmborg, Juan Manuel Reyes, Andreina Jose Alamo, sam rogers, Karan Thakkar, Kejal Hasmukharay, Asuka Yoshida, Zirk Wiid, Bradford D. Gessner and Elizabeth Begier
University of Washington - The Institute for Health Metrics and Evaluation, University of Washington - The Institute for Health Metrics and Evaluation, Pfizer, Inc., University of Washington - Institute for Health Metrics and Evaluation, University of Washington - Institute for Health Metrics and Evaluation, University of Washington - Institute for Health Metrics and Evaluation, Pfizer, Inc., Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Universiti Malaya, Pfizer, Inc., Pfizer, Inc., Pfizer Inc Pennsylvania and Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs
Downloads 82 (796,622)

Abstract:

Loading...

Respiratory syncytial virus, RSV, respiratory disease, cardiorespiratory disease, hospitalizations, Global Burden of Disease